medigraphic.com
ISSN 2539-0859 (Digital)
ISSN 0120-8411 (Impreso)
Asociación Colombiana de Otorrinolaringología y Cirugía de Cabeza y cuello, Maxilofacial y Estética Facial (ACORL)

2024, Número 3

<< Anterior Siguiente >>

Acta de Otorrinolaringología CCC 2024; 52 (3)


Guía para el diagnóstico y tratamiento de la parálisis facial periférica idiopática

González-Eslait F, Ruiz-Tejada E, Holguín-Ruiz JA, León-Sarmiento CE, Vélez-Rodríguez JJ

Idioma: Español
Referencias bibliográficas: 44
Paginas: 351-376
Archivo PDF: 779.40 Kb.


RESUMEN

La parálisis facial periférica idiopática ocupa el mayor porcentaje de todas las causas de parálisis facial, lo que representa aproximadamente el 60%-75%. Esta resulta de una alteración completa o parcial de los movimientos musculares de la hemicara afectada, como su nombre lo indica, su causa es desconocida, pero se han generado varias teorías y su diagnóstico es por exclusión. Se produce un déficit facial del tipo de motoneurona inferior, unilateral, de aparición rápida. Sin embargo, los pacientes pueden tener otros síntomas como hiperacusia, disgeusia, dolor facial y epífora. El diagnóstico diferencial de la parálisis facial es extenso y se puede dividir en amplias categorías como congénita, cerebrovascular, infecciosa, neoplásica, inflamatoria o autoinmune y traumática.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Saborío Cervantes IE, Villalobos Bonilla D, Bolaños Parajeles C. Abordaje de la parálisis de Bell: diagnóstico y tratamiento. RevistaMédica Sinergia. 2019;4(6):81–9. doi: 10.31434/rms.v4i6.247

  2. Zhang W, Xu L, Luo T, Wu F, Zhao B, Li X. The etiology of Bell’s palsy: a review. J Neurol. 2020;267(7):1896-1905. doi: 10.1007/s00415-019-09282-4

  3. Sweeney K. Evaluation and management of Bell’s Palsy. . Grand Rounds Presentation, UTMB. 2002.

  4. Vakharia K, Vakharia K. Bell’s Palsy. Facial Plast Surg Clin North Am. 2016;24(1):1-10. doi: 10.1016/j.fsc.2015.08.001

  5. Hohman MH, Hadlock TA. Etiology, diagnosis, and management of facial palsy: 2000 patients at a facial nerve center. In:Laryngoscope. John Wiley and Sons Inc.; 2014.

  6. Lassaletta L, Morales-Puebla JM, Altuna X, Arbizu Á, Arístegui M, Batuecas Á, et al. Facial paralysis: Clinical practice guideline ofthe Spanish Society of Otolaryngology. Acta Otorrinolaringol Esp (Engl Ed). 2020;71(2):99-118. English, Spanish. doi: 10.1016/j.otorri.2018.12.004

  7. Fieux M, Franco-Vidal V, Devic P, Bricaire F, Charpiot A, Darrouzet V, et al. Management of acute Bell’s palsy. Eur AnnOtorhinolaryngol Head Neck Dis. 2020;137(6):483-488. doi: 10.1016/j.anorl.2020.06.004

  8. Fattah AY, Gurusinghe ADR, Gavilan J, Hadlock TA, Marcus JR, Marres H, et al. Facial nerve grading instruments: systematic reviewof the literature and suggestion for uniformity. Plast Reconstr Surg. 2015;135(2):569-579. doi: 10.1097/PRS.0000000000000905

  9. Pauna HF, Silva VAR, Lavinsky J, Hyppolito MA, Vianna MF, Gouveia MCL, et al. Task force of the Brazilian Society of Otology -evaluation and management of peripheral facial palsy. Braz J Otorhinolaryngol. 2024;90(3):101374. doi: 10.1016/j.bjorl.2023.101374

  10. Urban E, Volk GF, Geißler K, Thielker J, Dittberner A, Klingner C, et al. Prognostic factors for the outcome of Bells’ palsy: A cohortregister-based study. Clin Otolaryngol. 2020;45(5):754-761. doi: 10.1111/coa.13571

  11. Mancini P, De Seta D, Prosperini L, Nicastri M, Gabriele M, Ceccanti M, et al. Prognostic factors of Bell’s palsy: multivariate analysisof electrophysiological findings. Laryngoscope. 2014;124(11):2598-605. doi: 10.1002/lary.24764

  12. Petrides GA, Hayler R, Lee JW, Jankelowitz S, Low TH. Electromyography in the prognostication of recovery in patients with acuteperipheral facial nerve palsy: A systematic review. Clin Otolaryngol. 2023;48(4):563-575. doi: 10.1111/coa.14072

  13. de Almeida JR, Guyatt GH, Sud S, Dorion J, Hill MD, Kolber MR, et al. Management of Bell palsy: clinical practice guideline.CMAJ. 2014;186(12):917-22. doi: 10.1503/cmaj.131801

  14. Kazemian E, Schaffer HM, Wozniak A, Leonetti JP. Economic Impact of Diagnostic Imaging in the Workup of Uncomplicated Bell’sPalsy. J Neurol Surg B Skull Base. 2021;83(3):323-327. doi: 10.1055/s-0040-1722231

  15. Madhok VB, Gagyor I, Daly F, Somasundara D, Sullivan M, Gammie F, et al. Corticosteroids for Bell’s palsy (idiopathic facialparalysis). Cochrane Database Syst Rev. 2016;7(7):CD001942. doi: 10.1002/14651858.CD001942.pub5

  16. Fujiwara T, Namekawa M, Kuriyama A, Tamaki H. High-dose Corticosteroids for Adult Bell’s Palsy: Systematic Review and Meta-analysis. Otol Neurotol. 2019;40(8):1101-1108. doi: 10.1097/MAO.0000000000002317

  17. Gagyor I, Madhok VB, Daly F, Sullivan F. Antiviral treatment for Bell’s palsy (idiopathic facial paralysis). Cochrane Database SystRev. 2019;9(9):CD001869. doi: 10.1002/14651858.CD001869.pub9

  18. Fujiwara T, Iwata S, Hosokawa Y, Mitani S. Intratympanic corticosteroid for Bell’s palsy and Ramsay Hunt syndrome: Systematicreview and meta-analysis. Auris Nasus Larynx. 2022;49(4):599-605. doi: 10.1016/j.anl.2021.12.005

  19. de Almeida JR, Al Khabori M, Guyatt GH, Witterick IJ, Lin VY, Nedzelski JM, et al. Combined corticosteroid and antiviral treatmentfor Bell palsy: a systematic review and meta-analysis. JAMA. 2009;302(9):985-93. doi: 10.1001/jama.2009.1243

  20. Li P, Qiu T, Qin C. Efficacy of Acupuncture for Bell’s Palsy: A Systematic Review and Meta-Analysis of Randomized ControlledTrials. PLoS One. 2015;10(5):e0121880. doi: 10.1371/journal.pone.0121880

  21. Singh S, Das AV, Ali MH. Ocular involvement in facial nerve paralysis: risk factors for severe visual impairment and ocular surfaceexposure in 1870 patients. Orbit. 2023;42(3):256-261. doi: 10.1080/01676830.2022.2090013

  22. Teixeira LJ, Valbuza JS, Prado GF. Physical therapy for Bell’s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev.2011;(12):CD006283. doi: 10.1002/14651858.CD006283.pub3

  23. Khan AJ, Szczepura A, Palmer S, Bark C, Neville C, Thomson D, et al. Physical therapy for facial nerve paralysis (Bell’s palsy):An updated and extended systematic review of the evidence for facial exercise therapy. Clin Rehabil. 2022;36(11):1424-1449. doi:10.1177/02692155221110727

  24. Zhou Y, Dong X, Xing Y, Wang R, Yang S, Han Y, et al. Effects of electroacupuncture therapy on intractable facial paralysis: A systematic review and meta-analysis. PLoS One. 2023;18(7):e0288606. doi: 10.1371/journal.pone.0288606

  25. Casazza GC, Schwartz SR, Gurgel RK. Systematic Review of Facial Nerve Outcomes After Middle Fossa Decompression andTransmastoid Decompression for Bell’s Palsy With Complete Facial Paralysis. Otol Neurotol. 2018;39(10):1311-1318. doi: 10.1097/MAO.0000000000001979

  26. Andresen NS, Sun DQ, Hansen MR. Facial nerve decompression. Curr Opin Otolaryngol Head Neck Surg. 2018;26(5):280-285. doi:10.1097/MOO.0000000000000478

  27. Kanerva M, Jones S, Pitkaranta A. Ramsay Hunt syndrome: characteristics and patient self-assessed long-term facial palsy outcome.Eur Arch Otorhinolaryngol. 2020;277(4):1235-1245. doi: 10.1007/s00405-020-05817-y

  28. van Oorschot D, Vroling H, Bunge E, Diaz-Decaro J, Curran D, Yawn B. A systematic literature review of herpes zoster incidenceworldwide. Hum Vaccin Immunother. 2021;17(6):1714-1732. doi: 10.1080/21645515.2020.1847582

  29. Patil A, Goldust M, Wollina U. Herpes zoster: A Review of Clinical Manifestations and Management. Viruses. 2022;14(2):192. doi:10.3390/v14020192

  30. Kremer H, Kuyt LP, van den Helm B, van Reen M, Leunissen JA, Hamel BC, et al. Localization of a gene for Möbius syndrome tochromosome 3q by linkage analysis in a Dutch family. Hum Mol Genet. 1996;5(9):1367-71. doi: 10.1093/hmg/5.9.1367

  31. Verzijl HT, van der Zwaag B, Lammens M, ten Donkelaar HJ, Padberg GW. The neuropathology of hereditary congenital facial palsyvs Möbius syndrome. Neurology. 2005;64(4):649-53. doi: 10.1212/01.WNL.0000151848.65094.55

  32. Verzijl HT, van den Helm B, Veldman B, Hamel BC, Kuyt LP, Padberg GW, et al. A second gene for autosomal dominant Möbiussyndrome is localized to chromosome 10q, in a Dutch family. Am J Hum Genet. 1999;65(3):752-6. doi: 10.1086/302539

  33. Jankauskienė A, Azukaitis K. Congenital unilateral facial nerve palsy as an unusual presentation of BOR syndrome. Eur J Pediatr.2013;172(2):273-5. doi: 10.1007/s00431-012-1795-4

  34. Traboulsi EI. Congenital cranial dysinnervation disorders and more. J AAPOS. 2007;11(3):215-7. doi: 10.1016/j.jaapos.2007.04.007

  35. Jones H, Hintze J, Slattery F, Gendre A. Bell’s palsy in pregnancy: A scoping review of risk factors, treatment and outcomes.Laryngoscope Investig Otolaryngol. 2023;8(5):1376-1383. doi: 10.1002/lio2.1136

  36. Wohrer D, Moulding T, Titomanlio L, Lenglart L. Acute Facial Nerve Palsy in Children: Gold Standard Management. Children(Basel). 2022;9(2):273. doi: 10.3390/children9020273

  37. Domeshek LF, Zuker RM, Borschel GH. Management of Bilateral Facial Palsy. Otolaryngol Clin North Am. 2018;51(6):1213-1226.doi: 10.1016/j.otc.2018.07.014

  38. Swami H, Dutta A, Nambiar S. Recurrent Bell’s Palsy. Med J Armed Forces India. 2010;66(1):95-6. doi: 10.1016/S0377-1237(10)80115-7

  39. Munjal M, Badyal HL, Mehndiratta A, Munjal S, Bharadwaj I, Kalra S, et al. Role of topodiagnostic tests in evaluation of facial nervepalsy in head injury. Int J Otorhinolaryngol Head Neck Surg. 2020;6(10):1874-7.

  40. Vajpayee D, Mallick A, Mishra AK. Post Temporal Bone Fracture Facial Paralysis: Strategies in Decision Making and Analysis ofEfficacy of Surgical Treatment. Indian J Otolaryngol Head Neck Surg. 2018;70(4):566-571. doi: 10.1007/s12070-018-1371-y

  41. Seo HW, Ryu S, Lee SH, Chung JH. Diabetes Mellitus and Acute Facial Palsy: A Nationwide Population-Based Study.Neuroepidemiology. 2024;58(1):37-46. doi: 10.1159/000534760

  42. Alam D, Islam MR, Habib R, Hossen Khan MS, Binte Rouf RS. Management of adult diabetic patients of Bell’s palsy with andwithout steroid: experience from a tertiary care hospital. Bangladesh Crit Care J. 2022;10(1), 33–37. doi: 10.3329/bccj.v10i1.59201

  43. Demir D, Genç S, Güven M, Yılmaz MS, Kara A, Erkorkmaz Ü. Intratympanic Steroid Treatment of Bell’s Palsy in Patients withComorbid Disease: A Preliminary Report. J Int Adv Otol. 2020;16(1):47-52. doi: 10.5152/iao.2019.5415

  44. Casano K, Giangrosso G, Mankekar G, Sevy A, Mehta R, Arriaga M. Additional Benefits of Facial Nerve Monitoring during OtologicSurgery. Otolaryngol Head Neck Surg. 2020;163(3):572-576. doi: 10.1177/0194599820915458




2020     |     www.medigraphic.com